News, Resources, & Updates

All
  • All
  • Articles
  • Calendar
  • Compliance
  • Newsletter
  • Position Statements
  • Press Release
  • Regulatory
  • Uncategorized

Case Study: Updating & Revising HPUS Monographs

By Eric Foxman, Pharm. (Ret.), AAHP Secretary What is the process through which the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) revises monographs? What...
FDA

Be ’Recall Ready’: FDA Wants to Help You Fulfill Your Regulatory Requirements

By Eric Foxman, AAHP Secretary Does your company market or distribute an FDA-regulated product? If so, then FDA has a document for you. FDA wants...

Homeopathic Community Responds to BJM Article on Reporting Bias

By Mark Land, AAHP President   You may have seen recent reports about a new study claiming that most homeopathic research is of poor quality,...

Mastering the Master Service Agreement (MSA)

Supply Chain Management for Homeopathy, Part 4 of 4 By Tim Clarot, Industry Consultant The final element of a good supply chain structure is the...
Dr Robert Califf

Meet the Incumbent FDA Commissioner, Robert Califf, MD

Prominent cardiologist Robert Califf, MD, will once again serve as FDA Commissioner after being confirmed by the Senate on Feb. 15. Dr. Califf was first...

Ushering in CPG 400.400 & Modern Homeopathy: Interview with Al Lorman

For those in the AAHP community who don't know him already, we're thrilled to introduce you to Alvin J. Lorman. Not only is Al our...

Homeopathic Community Mourns the Loss of Researcher Luc Montagnier

The French virologist Luc Montagnier who won the Nobel Prize in 2008 for discovering the AIDS virus passed away on Feb. 8, 2022 in the...

Congress Begins Work on FDA User Fee Reauthorization Measure

By Mark Land, AAHP President This year marks the 30th anniversary of the enactment of the Prescription Drug User Fee Act (PDUFA). Enacted in 1992,...

AAHP Submits Comments and Briefs Industry on New FDA Requirements

In November 2021, FDA announced a guidance regarding annual reporting of quantities of drugs manufactured or compounded. The deadline for the first reports, covering quantities...